Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Bromocriptine mesylate tablets (palmatine)

1. Endocrine system diseases: prolactin dependent menstrual cycle disorder and infertility (with high or normal prolactinemia), amenorrhea (with or without lactation), oligomenorrhea, luteal insufficiency and drug-induced hyperprolactinism (antipsychotics and hypertensive drugs). 2. Non prolactin dependent infertility: polycystic ovary syndrome combined with anti estrogen (such as chlorphenamine) in the treatment of anovulation. 3. Hyperprolactinoma: conservative treatment of small pituitary adenoma can inhibit the growth of adenoma or reduce the volume of adenoma before operation, making resection easy; It can be used to reduce still high prolactin levels after operation. 4. Acromegaly: the plasma level of growth hormone can be reduced by single application or combined with radiotherapy and surgery. 5. Inhibit physiological lactation: after delivery or abortion, inhibit breast congestion and swelling by inhibiting lactation, so as to prevent postpartum mastitis. 6. Benign breast diseases: alleviate or alleviate premenstrual syndrome and breast pain associated with breast nodule (or cystic) breast diseases. 7. Nervous system diseases: it is used for the treatment of Parkinson's disease caused by spontaneous and encephalitis in each stage alone or in combination with other anti Parkinson's disease drugs. 2.5mg (calculated by bromocriptine) More role
App download minus 10 yuan
Common name:
Bromocriptine mesylate tablets
Product No.:
C14202003433
Approval No.:
H20160170 (inquired by the State Drug Administration)
Jianke price:
¥112.00
Product specification:
2.5mg*30s
Manufacturer:
Gedeon Richter PLC
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Bromocriptine mesylate tablets (palmatine)
Main raw materials The active ingredient and its chemical name: bromocriptine mesylate.
Main role 1. Endocrine system diseases: prolactin dependent menstrual cycle disorder and infertility (with high or normal prolactinemia), amenorrhea (with or without lactation), oligomenorrhea, luteal insufficiency and drug-induced hyperprolactinism (antipsychotics and hypertensive drugs). 2. Non prolactin dependent infertility: polycystic ovary syndrome combined with anti estrogen (such as chlorphenamine) in the treatment of anovulation. 3. Hyperprolactinoma: conservative treatment of small pituitary adenoma can inhibit the growth of adenoma or reduce the volume of adenoma before operation, making resection easy; It can be used to reduce still high prolactin levels after operation. 4. Acromegaly: the plasma level of growth hormone can be reduced by single application or combined with radiotherapy and surgery. 5. Inhibit physiological lactation: after delivery or abortion, inhibit breast congestion and swelling by inhibiting lactation, so as to prevent postpartum mastitis. 6. Benign breast diseases: alleviate or alleviate premenstrual syndrome and breast pain associated with breast nodule (or cystic) breast diseases. 7. Nervous system diseases: it is used for the treatment of Parkinson's disease caused by spontaneous and encephalitis in each stage alone or in combination with other anti Parkinson's disease drugs. 2.5mg (calculated by bromocriptine)
Product specification 2.5mg*30s
Usage and dosage Should be taken orally with meals 1. Abnormal menstrual cycle and infertility: Take 1 / 2 tablets (1.25mg based on bromocriptine mesylate) once as needed, 2-3 times a day. If necessary, the dose can be increased to 1 tablet (2.5mg based on bromocriptine mesylate), 2-3 times a day. Treatment should be continued until the menstrual cycle returns to normal and / or ovulation is reoccurred. If necessary, it can be treated continuously for several cycles to prevent recurrence. 2. Hyperprolactinism: According to the needs, take 1 / 2 tablets once (1.25mg based on bromocriptine mesylate), 2-3 times a day, and gradually increase to 4-8 tablets a day (10-20mg based on bromocriptine mesylate). The specific scheme shall be determined according to the clinical efficacy and side effects. 3. Acromegaly: The recommended starting dose is 1-1.5 tablets a day (2.5-3.75mg based on bromocriptine mesylate), which is gradually increased to 4-8 tablets a day (10-20mg based on bromocriptine mesylate) according to clinical reactions and side effects. 4. Inhibition of lactation: Take 2 tablets a day (5 mg bromocriptine mesylate), 1 tablet in the morning and 1 tablet in the evening for 14 days. In order to prevent lactation, treatment should be started as soon as possible, but not earlier than 4 hours after delivery or abortion. A small amount of lactation will occur occasionally 2-3 days after the treatment is stopped. At this time, the original dose can be repeated for 1 week to stop lactation. 5. Puerperal breast swelling: Take one tablet at a time (2.5mg based on bromocriptine mesylate). If necessary, it can be taken repeatedly after 6-12 hours without inhibiting lactation. 6. Early postpartum mastitis: It should be used in combination with antibiotics. 7. Benign breast diseases: From 1 / 2 tablets a day (1.25mg based on bromocriptine mesylate), 2-3 times a day, gradually increased to 2-3 tablets a day. 8. Parkinson's disease: In the first week after treatment alone or combined with other drugs, take 1 / 2 tablets (1.25mg based on bromocriptine mesylate) before going to bed every day. The dose should be adjusted from the lowest effective dose. After the dose is increased by 1 / 2 tablets (1.25 mg of bromocriptine mesylate), the dose should be increased after continuous administration for 1 week. The oral dose should be divided into 2-3 times. Generally, it has obvious curative effect within 6-8 weeks. When the drug is treated alone or in combination with other drugs, the conventional dose of bromocriptine mesylate tablets is 4-16 tablets a day (10-40mg based on bromocriptine mesylate). In combination therapy, some patients may need a larger dose, which is an individualized difference. It is particularly important to give the lowest effective dose as far as possible under the condition of ensuring the best curative effect. After the side effects disappear, the dose can be increased again, and the maximum dose per day shall not be higher than 40 tablets (100 mg based on bromocriptine mesylate). Or follow your doctor's advice.
manufacturing enterprise Gedeon Richter PLC
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Bromocriptine mesylate tablets (palmatine)

[common name] Bromocriptine mesylate tablets

[specification and model] 2.5mg*30s

[manufacturer] Gedeon Richter PLC

[drug type] Western medicine

[approval No.] H20160170

[validity period] 36 months

[functional indications] 1. Endocrine system diseases: prolactin dependent menstrual cycle disorder and infertility (with high or normal prolactinemia), amenorrhea (with or without lactation), oligomenorrhea, luteal insufficiency and drug-induced hyperprolactinism (antipsychotics and hypertensive drugs). 2. Non prolactin dependent infertility: polycystic ovary syndrome combined with anti estrogen (such as chlorphenamine) in the treatment of anovulation. 3. Hyperprolactinoma: conservative treatment of small pituitary adenoma can inhibit the growth of adenoma or reduce the volume of adenoma before operation, making resection easy; It can be used to reduce still high prolactin levels after operation. 4. Acromegaly: the plasma level of growth hormone can be reduced by single application or combined with radiotherapy and surgery. 5. Inhibit physiological lactation: after delivery or abortion, inhibit breast congestion and swelling by inhibiting lactation, so as to prevent postpartum mastitis. 6. Benign breast diseases: alleviate or alleviate premenstrual syndrome and breast pain associated with breast nodule (or cystic) breast diseases. 7. Nervous system diseases: it is used for the treatment of Parkinson's disease caused by spontaneous and encephalitis in each stage alone or in combination with other anti Parkinson's disease drugs. 2.5mg (calculated by bromocriptine)

[usage and dosage] Should be taken orally with meals 1. Abnormal menstrual cycle and infertility: Take 1 / 2 tablets (1.25mg based on bromocriptine mesylate) once as needed, 2-3 times a day. If necessary, the dose can be increased to 1 tablet (2.5mg based on bromocriptine mesylate), 2-3 times a day. Treatment should be continued until the menstrual cycle returns to normal and / or ovulation is reoccurred. If necessary, it can be treated continuously for several cycles to prevent recurrence. 2. Hyperprolactinism: According to the needs, take 1 / 2 tablets once (1.25mg based on bromocriptine mesylate), 2-3 times a day, and gradually increase to 4-8 tablets a day (10-20mg based on bromocriptine mesylate). The specific scheme shall be determined according to the clinical efficacy and side effects. 3. Acromegaly: The recommended starting dose is 1-1.5 tablets a day (2.5-3.75mg based on bromocriptine mesylate), which is gradually increased to 4-8 tablets a day (10-20mg based on bromocriptine mesylate) according to clinical reactions and side effects. 4. Inhibition of lactation: Take 2 tablets a day (5 mg bromocriptine mesylate), 1 tablet in the morning and 1 tablet in the evening for 14 days. In order to prevent lactation, treatment should be started as soon as possible, but not earlier than 4 hours after delivery or abortion. A small amount of lactation will occur occasionally 2-3 days after the treatment is stopped. At this time, the original dose can be repeated for 1 week to stop lactation. 5. Puerperal breast swelling: Take one tablet at a time (2.5mg based on bromocriptine mesylate). If necessary, it can be taken repeatedly after 6-12 hours without inhibiting lactation. 6. Early postpartum mastitis: It should be used in combination with antibiotics. 7. Benign breast diseases: From 1 / 2 tablets a day (1.25mg based on bromocriptine mesylate), 2-3 times a day, gradually increased to 2-3 tablets a day. 8. Parkinson's disease: In the first week after treatment alone or combined with other drugs, take 1 / 2 tablets (1.25mg based on bromocriptine mesylate) before going to bed every day. The dose should be adjusted from the lowest effective dose. After the dose is increased by 1 / 2 tablets (1.25 mg of bromocriptine mesylate), the dose should be increased after continuous administration for 1 week. The oral dose should be divided into 2-3 times. Generally, it has obvious curative effect within 6-8 weeks. When the drug is treated alone or in combination with other drugs, the conventional dose of bromocriptine mesylate tablets is 4-16 tablets a day (10-40mg based on bromocriptine mesylate). In combination therapy, some patients may need a larger dose, which is an individualized difference. It is particularly important to give the lowest effective dose as far as possible under the condition of ensuring the best curative effect. After the side effects disappear, the dose can be increased again, and the maximum dose per day shall not be higher than 40 tablets (100 mg based on bromocriptine mesylate). Or follow your doctor's advice.

[adverse reactions] 1. Many patients may have nausea, vomiting, headache, dizziness or fatigue in the first few days after taking medicine, but they do not need to stop taking medicine. Taking some antiemetic drugs such as chengyuning, tolaikang and metoclopramide one hour before taking bromocriptine mesylate can inhibit nausea and dizziness. 2. In very few cases, postural hypotension occurs after taking this product. Therefore, it is recommended to measure standing blood pressure for patients who can walk. 3. During high-dose treatment, hallucinations, mental disorders, visual disorders, motor disorders, dry mouth, constipation, leg spasm, etc. may occur. These side effects are about dose-dependent, and the reduction can control the symptoms. In long-term treatment, especially for those with a history of Raynaud's phenomenon, reversible hypothermia may occasionally induce finger and toe pallor. 4. There have been cases of pathological gambling, increased libido and hypersexuality in foreign patients after using dopamine receptor agonists to treat Parkinson's disease. Especially at high doses, it can be reversed after reducing the treatment dose or stopping the drug.

[precautions] 1. After treatment with bromocriptine mesylate tablets, fertility may recover. Therefore, women of childbearing age who do not want to become pregnant should be advised to take reliable (non hormonal) contraceptive measures. Women of childbearing age who want to become pregnant should immediately terminate the treatment of bromocriptine mesylate tablets after they have been confirmed to be pregnant. The incidence of abortion did not increase after drug withdrawal, and bromocriptine mesylate tablets had no side effects on early pregnancy (within 8 weeks). When patients with pituitary adenoma stop taking bromocriptine mesylate tablets, they should be closely monitored throughout pregnancy, and it is necessary to have visual field examination regularly. 2. Patients with pituitary adenoma should be treated with bromocriptine mesylate tablets again when they have signs of tumor enlargement. When treating breast pain and nodular and / or cystic breast diseases, the possibility of malignant tumors should be excluded first. 3. Use this product to inhibit puerperal lactation. Especially in the first week of treatment, it is recommended to check blood pressure irregularly. In case of hypertension accompanied by persistent severe headache, the medication should be stopped immediately and the patient should be closely observed. 4. For acromegaly patients with a history of gastrointestinal bleeding, it is best to use alternative treatment. If bromocriptine mesylate tablets must be taken, they should also be informed to report any gastrointestinal reaction to the medical staff in time. 5. Patients with mental history or serious cardiovascular history should be cautious when taking high-dose bromocriptine mesylate. 6. When treating female patients not related to hyperprolactinemia, the lowest effective dose should be given to avoid that the plasma prolactin level is lower than the normal level, otherwise it may cause corpus luteum dysfunction. Postmenopausal women should be examined every six months. Please read the instructions carefully and follow the doctor's advice.

[taboo] It is forbidden to be allergic to any component in bromocriptine mesylate tablets. In psychiatry, spontaneous and familial tremor, Huntington's chorea, severe cardiovascular disease, various types of endogenous psychosis, untreated hypertension, pregnancy toxemia, allergy to other ergot alkaloids, and patients with existing valve disease are prohibited.

[listing Permit Holder] Gedeon Richter PLC

[packaging unit] bottle

[main ingredients] The active ingredient and its chemical name: bromocriptine mesylate.

[character] This product is a kind of white film, with a notch in the middle on one side and 2.5 on the other side.

[applicable population] adult

[medication for pregnant and lactating women] 1. Lactating women should not take bromocriptine mesylate tablets. 2. After pregnancy, you should usually stop taking this product after the seventh menopause. Pituitary tumors sometimes increase rapidly during pregnancy, which can also occur in women who have been able to conceive after treatment with bromocriptine mesylate tablets. For caution, patients should be closely monitored for signs of pituitary enlargement so that bromocriptine mesylate tablets can be reused if necessary. 3. Under special circumstances such as abortion, stillbirth and neonatal death, it is used to inhibit puerperal lactation under the guidance of doctors, and is not recommended as a routine drug to inhibit physiological lactation. 4. Postpartum or puerperal women with hypertension, coronary heart disease and / or serious mental history should not use this product. Postpartum women receiving bromocriptine mesylate tablets should pay attention to monitoring blood pressure, especially on the first day of treatment and postpartum women applying bromocriptine mesylate tablets to inhibit lactation, pay attention to antihypertensive drug treatment and avoid using other ergot derivatives at the same time, Hypertension, myocardial infarction, seizures or stroke and mental diseases have been rare.

[medication for children] There is no research data on the safety and efficacy of this product for children under 15 years old.

[medication for elderly patients] There is no safety and effectiveness research data.

[storage] Shading, airtight, moisture-proof, 15-25 degrees preservation.

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Bromocriptine mesylate tablets (palmatine)

    ¥112.00

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!